| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
402 |
| issn |
1472-4472 |
| issueIdentifier |
9 |
| pageRange |
1396-402 |
| publicationName |
Current opinion in investigational drugs (London, England : 2000) |
| startingPage |
1396 |
| bibliographicCitation |
Vigushin DM. FR-901228 Fujisawa/National Cancer Institute. Curr Opin Investig Drugs. 2002 Sep;3(9):1396–402. PMID: 12498018. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dabee7d2582d7a49d742c68c9b74f0e6 |
| date |
200209 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/12498018 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1472-4472
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22279 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
FR-901228 Fujisawa/National Cancer Institute |
| discusses |
http://id.nlm.nih.gov/mesh/M0458175
http://id.nlm.nih.gov/mesh/M0016239
http://id.nlm.nih.gov/mesh/M0527853
http://id.nlm.nih.gov/mesh/M0519758
http://id.nlm.nih.gov/mesh/M0010420 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D010456Q000627
http://id.nlm.nih.gov/mesh/D047630
http://id.nlm.nih.gov/mesh/D004345Q000379 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D056572
http://id.nlm.nih.gov/mesh/D009316
http://id.nlm.nih.gov/mesh/D006655Q000378
http://id.nlm.nih.gov/mesh/D014481
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D009369Q000188
http://id.nlm.nih.gov/mesh/D010456Q000737
http://id.nlm.nih.gov/mesh/D009369Q000378
http://id.nlm.nih.gov/mesh/D010456Q000494
http://id.nlm.nih.gov/mesh/D002986Q000379
http://id.nlm.nih.gov/mesh/D002986Q000706
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004345Q000331 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5352062
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 |